Skip to Content
A33 / P33
NCODA Oncology and Hematology Meeting Abstracts | Volume 2 | Supplement 2
Publication Date: October 13, 2026

Personalized oncology Patient Treatment Calendars to improve patient education, adherence, and care coordination

Authors:

Corinne Shamedhi, PA-C1; Natasha Olson, PharmD1

Organization / Company:

1NCODA, Cazenovia, NY, USA

NCODA Oncol Hematol Meet Abstr. 2026;2(suppl 2):abstr 33.

Background:

Oncology treatment regimens are increasingly complex, often requiring patients and caregivers to manage multiple oral and/or intravenous anticancer therapies, supportive care medications, laboratory monitoring, appointments, and toxicity reporting across multiple care settings. Gaps in patient understanding may contribute to missed doses, delayed symptom reporting, avoidable treatment interruptions, and increased burden on the oncology care team. Written and electronic education materials are recommended to supplement verbal counseling and reinforce key treatment information after the education visit.

 

Objective:
  • Describe how personalized oncology treatment calendars can support patient education, medication adherence, and symptom management.
  • Identify opportunities for advanced practitioners to incorporate treatment calendars into routine counseling, care coordination, and follow-up workflows for patients receiving complex anticancer therapy.

 

Purpose:

Network for Collaborative Oncology Development & Advancement’s (NCODA) Patient Treatment Calendars provide clinicians with a practical, patient-centered tool to create individualized treatment schedules that translate complex regimens into clear, actionable calendars. This poster highlights how treatment calendars can be used by advanced practitioners and oncology teams to improve communication, promote adherence, and support coordinated care.

 

Methods:

A practice-focused review was conducted to evaluate potential applications of NCODA Patient Treatment Calendars within oncology workflows. Use cases were mapped to common patient care touchpoints, including treatment initiation, regimen changes, oral anticancer medication education, supportive care counseling, toxicity monitoring, and follow-up visits. Prior to development of NCODA’s Patient Treatment Calendar platform, oncology practices commonly relied on handwritten calendars, which may be time-intensive to create, limited by space and clarity, difficult to standardize, and unable to integrate with technology-based workflows. Calendar elements were assessed for their ability to reinforce regimen-specific instructions, align team communication, and provide patients and caregivers with a shared reference throughout treatment.

 

Results:

Patient Treatment Calendars strengthen oncology care by organizing treatment dates, medication administration instructions, supportive care, appointment schedules, and monitoring needs in a patient-friendly format. Integration into education visits helps advanced practitioners verify understanding, reinforce missed-dose and adverse event instructions, and identify barriers to adherence. Calendars also offer a standardized tool for interprofessional teams, including pharmacists, nurses, advanced practice providers, physicians, and patient navigators, to align messaging and reduce fragmented communication. In settings managing anticancer medications, calendars may complement structured education checklists and follow-up workflows by providing patients with a clear visual plan for therapy.

 

Conclusion:

Personalized treatment calendars represent a scalable, low-burden strategy to improve patient education and care coordination in oncology practice. Incorporating NCODA Patient Treatment Calendars into routine counseling helps patients and caregivers better understand complex regimens, adhere to treatment, and improve communication with the oncology team. Future evaluation should measure the impact on patient satisfaction, adherence, call volume, toxicity reporting, and treatment delays.

Funding: Not Applicable.

 

Peer Review Disclosure:

Authors of this abstract serve as a Peer Reviewers for NOHMA and was recused from its peer review and acceptance recommendation. The abstract was independently reviewed and approved without the author’s involvement.

 

A33 / P33